Back
Adaptimmune Therapeutics PLC Stock Price Chart
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.45
Seasonality Move:
26.85%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and ADAP is experiencing slight buying pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.47 | Sell |
| 20-day SMA: | 0.52 | Sell |
| 50-day SMA: | 0.57 | Sell |
| 200-day SMA: | 0.85 | Sell |
| 8-day EMA: | 0.47 | Sell |
| 20-day EMA: | 0.51 | Sell |
| 50-day EMA: | 0.56 | Sell |
| 200-day EMA: | 0.78 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 33.44 | Sell |
| Chaikin Money Flow: | -343901 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.48 - 0.6) | Sell |
| Bollinger Bands (100): | (0.53 - 0.73) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
| Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.46 while ADAP 8-day simple moving average is 0.47, which is a Sell signal.
-
The stock price of ADAP is 0.46 while Adaptimmune Therapeutics PLC 20-day SMA is 0.52, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day simple moving average is 0.57 while ADAP share price is 0.46, making it a Sell technically.
-
ADAP stock price is 0.46 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.85, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
25
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a SellThe current Adaptimmune Therapeutics PLC [ADAP] share price is $0.46. The Score for ADAP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
116.9M
Price in USD:
0.46
Share Volume:
1.4M
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
1.65
52-Week Low:
0.44
Sell
25
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?The Adaptimmune Therapeutics PLC stock price is 0.46 USD today.
-
Will ADAP stock go up or go down?Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptimmune Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.46 while ADAP 8-day exponential moving average is 0.47, which is a Sell signal.
-
The stock price of ADAP is 0.46 while Adaptimmune Therapeutics PLC 20-day EMA is 0.51, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day exponential moving average is 0.56 while ADAP share price is 0.46, making it a Sell technically.
-
ADAP stock price is 0.46 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.78, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
-
ADAP Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Adaptimmune Therapeutics PLC is a Sell
-
Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 33.44, which suggest Adaptimmune Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.48 - 0.6), which suggest Adaptimmune Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.53 - 0.73), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.